Follow the people · Insider

GS

Gaurav Shah

Insider · CEO · RCKT

Gaurav Shah files insider transactions with the SEC as a ceo of Rocket Pharmaceuticals (RCKT). We hold 7 disclosed purchases and sales filed since 2 April 2018, 2 of them in the last 90 days.

  • Files forRCKT
  • Disclosed buys and sells7 in all, 2 in the last 90 days
  • Last disclosure20 August 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 29 March 201818 August 2026CEO · Rocket Pharmaceuticals (RCKT)90 Form 4 lines · source: SEC Form 4
  • Filed 9 June 202213 June 2023Director · Talaris Therapeutics (TALS)2 Form 4 lines · source: SEC Form 4

Everything they disclosed

92 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.